Center for Scientific Review Amended Notice of Meeting
---
identifier: "/us/fr/2020-05418"
source: "fr"
legal_status: "authoritative_unofficial"
title: "Center for Scientific Review Amended Notice of Meeting"
title_number: 0
title_name: "Federal Register"
section_number: "2020-05418"
section_name: "Center for Scientific Review Amended Notice of Meeting"
positive_law: false
currency: "2020-03-17"
last_updated: "2020-03-17"
format_version: "1.1.0"
generator: "[email protected]"
agency: "Health and Human Services Department"
document_number: "2020-05418"
document_type: "notice"
publication_date: "2020-03-17"
agencies:
- "Health and Human Services Department"
- "National Institutes of Health"
fr_citation: "85 FR 15207"
fr_volume: 85
---
# Center for Scientific Review Amended Notice of Meeting
Notice is hereby given of a change in the meeting of the HIV Immunopathogenesis and Vaccine Development Study Section, March 19, 2020, 8:00 a.m. to March 20, 2020 6:00 p.m., at the Fairmont Washington, DC, 2401 M Street NW, Washington, DC 20037, which was published in the *Federal Register* on February 20, 2020, 85 FR 9791.
The meeting will be held at the National Institutes of Health, 6701 Rockledge Drive Bethesda, MD 20892. The format of the meeting has been changed to a Video Assisted Meeting. The meeting date and time remain the same. The meeting is closed to the public.
Dated: March 11, 2020.
Miguelina Perez,
Program Analyst, Office of Federal Advisory Committee Policy.